Here's What to Expect From Church & Dwight's Next Earnings Report

via Barchart.com
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Ewing, New Jersey-based Church & Dwight Co., Inc. (CHD) develops, manufactures, and markets household, personal care, and specialty products. Valued at $22.9 billion by market cap, the company offers contraceptive products, laundry and dishwashing detergents, toothbrushes, shampoos, vitamins, pregnancy test kits, and hair removers. The leading U.S. producer of sodium bicarbonate is expected to announce its fiscal first-quarter earnings for 2026 before the market opens on Friday, May 1. 

Ahead of the event, analysts expect CHD to report a profit of $0.93 per share on a diluted basis, up 2.2% from $0.91 per share in the year-ago quarter. The company has consistently surpassed Wall Street’s EPS estimates in its last four quarterly reports. 

More Top Stocks Daily: Go behind Wall Street’s hottest headlines with Barchart’s Active Investor newsletter.

 

For the full year, analysts expect CHD to report EPS of $3.75, up 6.2% from $3.53 in fiscal 2025. Similarly, its EPS is expected to rise 6.7% year over year to $4 in fiscal 2027.

www.barchart.com

CHD stock has notably underperformed the S&P 500 Index’s ($SPX) 34.9% gains over the past 52 weeks, with shares down 8.1% during this period. Similarly, it underperformed the State Street Consumer Staples Select Sector SPDR ETF’s (XLPmarginal returns over the same time frame.

www.barchart.com

On Jan. 30, CHD shares closed up by 4.7% after reporting its Q4 results. Its adjusted EPS of $0.86 exceeded Wall Street expectations of $0.84. The company’s revenue was $1.6 billion, meeting Wall Street forecasts.

Analysts’ consensus opinion on CHD stock is reasonably bullish, with a “Moderate Buy” rating overall. Out of 20 analysts covering the stock, eight advise a “Strong Buy” rating, two suggest a “Moderate Buy,” nine give a “Hold,” and one recommends a “Strong Sell.” CHD’s average analyst price target is $103.33, indicating a potential upside of 6.7% from the current levels.


On the date of publication, Neha Panjwani did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.

 

More news from Barchart

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article